title: Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.
abstract: Viral infections of the central nervous system(CNS) mostly represent clinically important, often life-threatening complications of systemic viral infections. After acute measles, CNS complications may occur early (acute postinfectious measles encephalitis, APME) or after years of viral persistence (subacute sclerosing panencephalitis, SSPE). In spite of a presumably functional cell-mediated immunity and high antiviral antibody titers, an immunological control of the CNS infection is not achieved in patients suffering from SSPE. There is still no specific therapy for acute complications and persistent MV infections of the CNS. Hamsters, rats, and (genetically unmodified and modified) mice have been used as model systems to study mechanisms of MV-induced CNS infections. Functional CD4+ and CD8+ T cells together with IFN-gamma are required to overcome the infection. With the help of recombinant measles viruses and mice expressing endogenous or transgenic receptors, interesting aspects such as receptor-dependent viral spread and viral determinants of virulence have been investigated. However, many questions concerning the lack of efficient immune control in the CNS are still open. Recent research opened new perspectives using specific antivirals such as short interfering RNA (siRNA) or small molecule inhibitors. Inspite of obvious hurdles, these treatments are the most promising approaches to future therapies.
authors.affiliation: Institute for Virology and Immunobiology, University of Würzburg, Versbacher Str. 7, Würzburg, Germany.
authors.forename: Dajana
authors.initials: D
authors.lastname: Reuter
authors.forename: Jürgen
authors.initials: J
authors.lastname: Schneider-Schaulies
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D006224:Cricetinae; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology / Q000378:metabolism; D008459:Measles virus / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity; D051379:Mice; D023421:Models, Animal; D034741:RNA, Small Interfering / Q000627:therapeutic use; D051381:Rats; D013344:Subacute Sclerosing Panencephalitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology* / Q000821:virology
chemical_list: D000998:Antiviral Agents; D034741:RNA, Small Interfering; D007371:Interferon-gamma
references.citation: J Virol. 2001 Aug;75(16):7612-20
references.pmid: 11462033
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4659-63
references.pmid: 9114047
references.citation: J Virol. 1993 Aug;67(8):4760-8
references.pmid: 8392613
references.citation: Virology. 2001 Dec 20;291(2):215-25
references.pmid: 11878891
references.citation: J Virol. 1999 Mar;73(3):1795-801
references.pmid: 9971756
references.citation: J Virol. 2006 Oct;80(19):9361-70
references.pmid: 16973542
references.citation: J Gen Virol. 2007 Nov;88(Pt 11):3112-3120
references.pmid: 17947537
references.citation: Nature. 2000 Aug 24;406(6798):893-7
references.pmid: 10972291
references.citation: J Virol. 2001 Apr;75(7):3059-65
references.pmid: 11238832
references.citation: Epidemiol Infect. 2003 Oct;131(2):887-98
references.pmid: 14596530
references.citation: Drug Saf. 1998 Dec;19(6):435-54
references.pmid: 9880088
references.citation: J Infect Dis. 2005 Nov 15;192(10):1686-93
references.pmid: 16235165
references.citation: J Virol. 2007 Nov;81(21):12066-70
references.pmid: 17699577
references.citation: Clin Diagn Virol. 1995 Aug;4(2):135-47
references.pmid: 15566835
references.citation: J Gen Virol. 2001 Aug;82(Pt 8):1835-1844
references.pmid: 11457989
references.citation: J Neurovirol. 2002 Aug;8(4):335-44
references.pmid: 12161818
references.citation: Neuropediatrics. 2006 Aug;37(4):222-8
references.pmid: 17177148
references.citation: J Neuroimmunol. 1999 May 3;96(2):207-17
references.pmid: 10337919
references.citation: Neuropathol Appl Neurobiol. 1991 Aug;17(4):289-97
references.pmid: 1944804
references.citation: Nature. 1995 Jul 20;376(6537):260-3
references.pmid: 7617038
references.citation: J Virol. 1995 Aug;69(8):5191-4
references.pmid: 7609093
references.citation: J Neurovirol. 1997 Aug;3(4):304-9
references.pmid: 9291239
references.citation: J Gen Virol. 2003 Aug;84(Pt 8):2133-2143
references.pmid: 12867645
references.citation: Antiviral Res. 2009 Mar;81(3):261-6
references.pmid: 19133295
references.citation: J Child Neurol. 2007 Mar;22(3):341-3
references.pmid: 17621509
references.citation: Cell. 1988 Oct 21;55(2):255-65
references.pmid: 3167982
references.citation: J Virol. 2005 Jun;79(12):7768-76
references.pmid: 15919929
references.citation: J Virol. 2009 Jun;83(11):5544-55
references.pmid: 19321604
references.citation: J Virol. 1993 Oct;67(10):6025-32
references.pmid: 8371352
references.citation: J Immunol. 1999 Apr 1;162(7):4024-9
references.pmid: 10201924
references.citation: J Gen Virol. 1997 Jan;78 ( Pt 1):97-106
references.pmid: 9010291
references.citation: Virology. 2006 Mar 30;347(1):234-45
references.pmid: 16529787
references.citation: Cytokine. 2005 Oct 21;32(2):104-10
references.pmid: 16226466
references.citation: Virus Res. 2004 Jan;99(1):51-6
references.pmid: 14687946
references.citation: Neurology. 2004 Feb 10;62(3):457-60
references.pmid: 14872030
references.citation: J Gen Virol. 1998 Nov;79 ( Pt 11):2583-91
references.pmid: 9820133
references.citation: Int J Pharm. 2008 Jun 5;357(1-2):148-53
references.pmid: 18329830
references.citation: J Gen Virol. 2000 Nov;81(Pt 11):2707-2713
references.pmid: 11038383
references.citation: J Virol. 1996 Oct;70(10):6673-81
references.pmid: 8794303
references.citation: J Virol. 1997 Oct;71(10):7969-73
references.pmid: 9311889
references.citation: J Exp Med. 2005 Nov 7;202(9):1185-90
references.pmid: 16260490
references.citation: J Neurol. 2008 Dec;255(12):1861-71
references.pmid: 18846316
references.citation: J Neurovirol. 2001 Feb;7(1):25-34
references.pmid: 11519479
references.citation: Eur J Immunol. 2010 Feb;40(2):388-95
references.pmid: 19950186
references.citation: J Immunol. 1974 Oct;113(4):1205-9
references.pmid: 4606230
references.citation: J Med Virol. 1997 Aug;52(4):362-9
references.pmid: 9260681
references.citation: J Neuropathol Exp Neurol. 1996 Apr;55(4):471-80
references.pmid: 8786407
references.citation: J Pathol. 2006 Jan;208(2):199-214
references.pmid: 16362981
references.citation: J Virol. 1995 Sep;69(9):5469-74
references.pmid: 7636992
references.citation: PLoS One. 2009;4(3):e4948
references.pmid: 19319188
references.citation: J Neurovirol. 2002 Feb;8(1):6-13
references.pmid: 11847587
references.citation: Nat Immunol. 2001 Jan;2(1):64-8
references.pmid: 11135580
references.citation: J Virol. 1988 Apr;62(4):1388-97
references.pmid: 3346948
references.citation: J Virol. 2008 Nov;82(22):11273-82
references.pmid: 18768959
references.citation: Nat Rev Immunol. 2008 Sep;8(9):685-98
references.pmid: 19172691
references.citation: Cochrane Database Syst Rev. 2005 Oct 19;(4):CD001479
references.pmid: 16235283
references.citation: J Virol. 1999 Nov;73(11):9568-75
references.pmid: 10516065
references.citation: J Trop Pediatr. 2002 Apr;48(2):72-7
references.pmid: 12022432
references.citation: Neurol Neurocir Psiquiatr. 1977;18(2-3 Suppl):495-507
references.pmid: 616550
references.citation: Nature. 1981 Apr 16;290(5807):588-9
references.pmid: 6783963
references.citation: J Neuroimmunol. 1984 Dec;7(2-3):77-89
references.pmid: 6511890
references.citation: Neuropathol Appl Neurobiol. 2008 Aug;34(4):424-34
references.pmid: 17986184
references.citation: J Gen Virol. 1997 Jun;78 ( Pt 6):1295-302
references.pmid: 9191921
references.citation: J Med Chem. 2006 Aug 24;49(17):5080-92
references.pmid: 16913698
references.citation: J Virol. 1999 Aug;73(8):6916-22
references.pmid: 10400789
references.citation: Intervirology. 1997;40(2-3):176-84
references.pmid: 9450234
references.citation: Antiviral Res. 2006 Jul;70(3):105-11
references.pmid: 16530274
references.citation: Virology. 2007 Feb 20;358(2):251-7
references.pmid: 17070884
references.citation: J Neurol Sci. 2004 Aug 30;223(2):113-9
references.pmid: 15337611
references.citation: Postgrad Med J. 2002 Feb;78(916):63-70
references.pmid: 11807185
references.citation: J Virol. 2002 Jun;76(11):5720-8
references.pmid: 11992000
references.citation: Bioorg Med Chem Lett. 2007 Sep 15;17(18):5199-203
references.pmid: 17643302
references.citation: J Virol. 2002 May;76(9):4497-506
references.pmid: 11932415
references.citation: J Virol. 2001 May;75(10):4499-505
references.pmid: 11312320
references.citation: J Virol. 1998 Sep;72(9):7420-7
references.pmid: 9696838
references.citation: Virus Res. 1995 Jan;35(1):1-16
references.pmid: 7754670
references.citation: Curr Top Microbiol Immunol. 2009;330:243-69
references.pmid: 19203113
references.citation: J Neurovirol. 2007 Oct;13(5):410-5
references.pmid: 17994425
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16415-20
references.pmid: 16260741
references.citation: J Neuroimmunol. 2005 Dec 30;170(1-2):179-85
references.pmid: 16223530
references.citation: Microbiol Immunol. 2006;50(7):525-34
references.pmid: 16858143
references.citation: J Virol. 2008 May;82(9):4630-7
references.pmid: 18287234
references.citation: J Virol. 2006 Jul;80(13):6420-9
references.pmid: 16775330
references.citation: Brain Res. 2004 Apr 9;1004(1-2):73-82
references.pmid: 15033421
references.citation: Brain Dev. 2010 Jun;32(6):463-6
references.pmid: 19481385
references.citation: Thromb Haemost. 2009 Dec;102(6):1050-6
references.pmid: 19967134
references.citation: J Nutr. 2007 Aug;137(8):1916-22
references.pmid: 17634264
references.citation: Antimicrob Agents Chemother. 2007 Jul;51(7):2293-303
references.pmid: 17470652
references.citation: Int J Epidemiol. 2007 Dec;36(6):1334-48
references.pmid: 18037676
references.citation: J Virol. 2000 Aug;74(16):7478-84
references.pmid: 10906201
references.citation: J Virol. 1994 Mar;68(3):1532-43
references.pmid: 8107216
references.citation: J Gen Virol. 2006 Jul;87(Pt 7):2011-2019
references.pmid: 16760404
references.citation: J Neurovirol. 2000 Apr;6(2):121-6
references.pmid: 10822325
references.citation: J Virol. 2007 Nov;81(21):12091-6
references.pmid: 17715217
references.citation: J Med Chem. 2008 Jul 10;51(13):3731-41
references.pmid: 18529043
references.citation: Virology. 2007 May 25;362(1):235-44
references.pmid: 17434199
references.citation: J Virol. 1992 Sep;66(9):5534-41
references.pmid: 1501288
references.citation: Proc Natl Acad Sci U S A. 1988 Feb;85(4):1252-6
references.pmid: 3422488
references.citation: J Virol. 1993 Jan;67(1):75-81
references.pmid: 8093223
references.citation: J Virol. 2000 Feb;74(3):1373-82
references.pmid: 10627548
references.citation: PLoS Pathog. 2007 Nov;3(11):e178
references.pmid: 18020706
references.citation: J Virol. 2009 Sep;83(18):9423-31
references.pmid: 19587038
references.citation: Antiviral Res. 2004 Jun;62(3):135-7
references.pmid: 15130537
references.citation: J Gen Virol. 2001 Dec;82(Pt 12):2913-2917
references.pmid: 11714966
references.citation: Lancet. 1987 May 9;1(8541):1067-8
references.pmid: 2883399
references.citation: Eur J Neurosci. 1991 Oct;3(1):66-71
references.pmid: 12106270
references.citation: Antimicrob Agents Chemother. 2005 Sep;49(9):3755-61
references.pmid: 16127050
references.citation: Lab Invest. 2002 Apr;82(4):403-9
references.pmid: 11950898
references.citation: Antiviral Res. 2008 Oct;80(1):45-53
references.pmid: 18547655
references.citation: J Gen Virol. 1985 Jul;66 ( Pt 7):1411-21
references.pmid: 4020346
references.citation: Neuropathol Appl Neurobiol. 2003 Jun;29(3):273-9
references.pmid: 12787324
references.citation: Antiviral Res. 2008 Nov;80(2):158-67
references.pmid: 18634829
references.citation: Cell. 1999 Sep 3;98(5):629-40
references.pmid: 10490102
references.citation: J Virol. 2000 Feb;74(4):1908-18
references.pmid: 10644364
references.citation: Cell. 1993 Oct 22;75(2):295-305
references.pmid: 8402913
references.citation: Cytokine. 2006 Jan 7;33(1):17-20
references.pmid: 16413199
references.citation: Arch Neurol. 2002 May;59(5):822-7
references.pmid: 12020266
references.citation: J Immunol. 1980 Jul;125(1):78-85
references.pmid: 7381212
references.citation: J Virol. 2006 Jun;80(12):5951-7
references.pmid: 16731933
references.citation: J Neurovirol. 2008 Nov;14(6):486-91
references.pmid: 19016379
references.citation: J Gen Virol. 1997 Dec;78 ( Pt 12):3227-32
references.pmid: 9400973
references.citation: EMBO J. 1998 Jul 15;17(14):3899-908
references.pmid: 9670007
references.citation: J Clin Invest. 1995 Nov;96(5):2478-81
references.pmid: 7593637
references.citation: J Immunol. 2005 Sep 1;175(5):3252-61
references.pmid: 16116216
references.citation: Virology. 2001 Jan 5;279(1):9-21
references.pmid: 11145884
references.citation: J Virol. 1986 Aug;59(2):472-8
references.pmid: 3735490
references.citation: Immunology. 1994 Oct;83(2):184-9
references.pmid: 7835934
references.citation: Antimicrob Agents Chemother. 1973 Feb;3(2):235-41
references.pmid: 4208281
references.citation: Antimicrob Agents Chemother. 1996 Jan;40(1):241-3
references.pmid: 8787915
references.citation: J Clin Virol. 1999 May;12(3):201-10
references.pmid: 10382817
references.citation: J Immunol. 2003 Sep 15;171(6):3102-9
references.pmid: 12960336
references.citation: Antimicrob Agents Chemother. 2009 Sep;53(9):3860-70
references.pmid: 19528268
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5628-33
references.pmid: 15056763
references.citation: J Clin Invest. 2008 Jul;118(7):2448-58
references.pmid: 18568079
references.citation: FASEB J. 2009 Sep;23(9):3203-12
references.pmid: 19447880
references.citation: Antimicrob Agents Chemother. 1994 Apr;38(4):653-5
references.pmid: 8031027
references.citation: Acta Neuropathol. 1997 Nov;94(5):444-9
references.pmid: 9386776
references.citation: J Virol. 1994 Nov;68(11):6910-7
references.pmid: 7933071